September 16, 2019 – September 19, 2019

Boston, MA

Visit us at booth 502!

Presentation by:

Kari Wong, PhD,  Senior Study Director, Discovery and Translational Sciences, Metabolon, Inc.

Precision Metabolomics: Understanding the Complexity of NAFLD/NASH

September 17, 2019 at 2:55 PM

Disease drivers including genetics, environmental cues and microbiota drive the development of nonalcoholic-steatohepatitis(NASH).  The constellation of factors inciting NASH has spawned a remarkable array of targets.  A tool for augmenting the challenges of R&D programs is Metabolon’s Metabolomics platform. By identifying 1000+ metabolites in a single sample across pathways that underly NASH pathogenesis, key insights of target/molecule combinations can be illuminated with this platform.  This approach can be applied at any stage of drug development.

More information